Read “Ending HIV? Sangamo Therapeutics and Gene Editing” on pages 167-175.
Then, Answer the following questions (with at least eight  peer-reviewed sources):
- What were the pros and cons of Sangamo Therapeutics, Inc. (Sangamo) pursuing its gene editing programs alone versus working with a partner?
- What legal protections needed to be considered?
- Does the HIV program offer any special opportunities or challenges?
- What do you believe Sangamo should do regarding the HIV program?
- Should it license the technology to a large pharmaceutical company?
- Should it form a joint venture with another biotech or pharma company? If so, who?
Write a detailed 3-5 page report formatted in APA with a minimum of eight (8) peer-reviewed sources..